U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT06799598) titled 'DUOSTIM and AI: is There a Difference Between Oocyte Performance in the Follicular and Luteal Phases?' on Jan. 23.
Brief Summary: In vitro fertilization (IVF) has revolutionized assisted reproductive techniques, bringing hope to thousands of people seeking to fulfill their dream of parenthood. However, patients with low ovarian reserve face additional challenges, such as limited response to ovarian stimulation and difficulty in obtaining good-quality eggs. Innovative protocols such as Duostim (dual stimulation) have shown promise in these cases, allowing the maximum number of eggs to be retrieved in a short period of time. In additi...